170 related articles for article (PubMed ID: 33528707)
1. ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.
Lv M; Luo S
Ann Surg Oncol; 2021 Sep; 28(9):5110-5111. PubMed ID: 33528707
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
Millen EC; Cavalcante FP
Ann Surg Oncol; 2022 Feb; 29(2):1096-1097. PubMed ID: 34561776
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?
Chung SH; Cassidy MR
Ann Surg Oncol; 2023 Sep; 30(9):5619-5620. PubMed ID: 37191857
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Mamtani A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
Piltin MA; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
Okuno J; Miyake T; Shimazu K; Noguchi S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):810-811. PubMed ID: 32632881
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
Castelo M; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
Murphy BL; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.
Wong SM; Boileau JF
Ann Surg Oncol; 2021 May; 28(5):2630-2631. PubMed ID: 33123855
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
Vicini E; Fontana SKR; Leonardi MC; Veronesi P; Galimberti V
Ann Surg Oncol; 2022 Mar; 29(3):1761-1762. PubMed ID: 34757548
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Future View: A Recent Scientific Contribution Towards a Staging Revision of Contralateral Axillary Lymph Node Metastases from Breast Cancer.
Magnoni F; Intra M
Ann Surg Oncol; 2020 Oct; 27(11):4500-4501. PubMed ID: 32430751
[No Abstract] [Full Text] [Related]
12. ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer-Need for Clinical Trials to Reassess Standard of Care.
Postlewait LM; Lucci A
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):676-677. PubMed ID: 32737697
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Fluorescence-Guided Sentinel Node Biopsy for Breast Cancer.
Kedrzycki MS; Elson DS; Leff DR
Ann Surg Oncol; 2021 Jul; 28(7):3749-3750. PubMed ID: 33185734
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
Almahariq MF; Chen PY; Dekhne N; Dilworth JT
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):869-870. PubMed ID: 32737699
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Preoperative Nomogram Identifies Patients for Selective Omission of SLNB in Breast Cancer-to Promote Implementation of the Choosing Wisely Campaign Recommendations.
Tran HT; Jackson RS
Ann Surg Oncol; 2020 Aug; 27(8):2687-2688. PubMed ID: 32350715
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in Older Patients with ER+/Her2- Breast Cancer.
Chung A
Ann Surg Oncol; 2024 May; 31(5):3198-3199. PubMed ID: 38383660
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Validation Based on Low-Volume Metastasis of the Sentinel Lymph Node Biopsy in Early-Stage Cervical Cancer.
Guani B; Mathevet P
Ann Surg Oncol; 2021 Jul; 28(7):3636. PubMed ID: 33216267
[No Abstract] [Full Text] [Related]
18. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
19. Can axillary lymph node dissection be safely omitted for early-stage breast cancer patients with sentinel lymph node micrometastasis?
Damle S; Teal CB
Ann Surg Oncol; 2009 Dec; 16(12):3215-6. PubMed ID: 19777183
[No Abstract] [Full Text] [Related]
20. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
